장기 보존 시장 규모, 점유율, 동향 분석 보고서 : 솔루션별, 장기별, 보존 기술별, 지역별 및 부문별 예측(2026-2033년)

Organ Preservation Market Summary

The global organ preservation market size was valued at USD 291.2 million in 2025 and is projected to grow from USD 311.1 million in 2026 to USD 516.9 million by 2033, at a CAGR of 7.5% from 2026 to 2033. North America held the largest share of 45.3% in the global market in 2025. Market growth is driven by rising demand for organ transplants, technological advancements, an aging population, and proactive government initiatives.

According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants. This significant increase in the elderly population will intensify the demand for effective preservation solutions, particularly for kidney, liver, and heart transplants, as more elderly patients require these critical procedures. Government initiatives further bolster the organ preservation market by enhancing organ donation rates through awareness campaigns and funding. For instance, in February 2023, the Indian Express reported that the Brihanmumbai Municipal Corporation (BMC) allocated approximately USD 924 million to improve healthcare services and raise awareness of organ donation. Such governmental support is vital in driving the need for efficient preservation methods, particularly in emerging markets such as the Asia Pacific, where healthcare expenditures are rising. This convergence of factors is preparing the organ preservation industry for substantial growth in the coming years.

One of the major growth drivers for the market is the increasing adoption of advanced preservation technologies such as hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP). These technologies are increasingly preferred over traditional preservation methods because they help reduce ischemic injury, improve organ assessment, extend preservation time, and increase the utilization of marginal donor organs. The transition from static cold storage to dynamic machine perfusion systems is transforming transplant procedures globally and improving organ transport efficiency.

Advanced perfusion systems are especially gaining traction in heart, liver, and lung transplantation procedures, where maintaining organ functionality during transportation is critical. In 2024, TransMedics Group reported continued expansion in the clinical adoption of its Organ Care System (OCS) platforms for heart, lung, and liver transplantation across transplant centers in the U.S., highlighting the growing acceptance of portable organ perfusion technologies.

Growing government initiatives and organ donation awareness campaigns are also contributing significantly to market expansion. Several countries are strengthening organ donation infrastructure and implementing public awareness programs to reduce transplant waiting lists and improve donor organ availability. In the UK, NHS Blood and Transplant continues to promote nationwide organ donation campaigns and improve transplant logistics infrastructure to enhance donor organ utilization and reduce organ discard rates. Similarly, the U.S. government and United Network for Organ Sharing (UNOS) have expanded efforts focused on improving organ procurement efficiency and transplantation accessibility across the country.

The market is also benefiting from the increasing use of donation after circulatory death (DCD) organs and the growing focus on expanding the donor organ pool. Advanced preservation technologies are enabling transplant centers to successfully preserve and assess marginal donor organs that were previously considered unsuitable for transplantation. In 2025, Mayo Clinic highlighted ongoing advancements in ex vivo organ perfusion and donor organ rehabilitation technologies to improve preservation times and increase transplantation success rates for high-risk donor organs. Such developments are expected to improve donor organ utilization and support long-term market growth.

Global Organ Preservation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global organ preservation market report based on solution, organ, preservation technique, and region:

• Solution Outlook (Revenue, USD Million, 2021 - 2033)
• University of Wisconsin (UW)
• Custodiol HTK
• Perfadex
• Others
• Organ Type Outlook (Revenue, USD Million, 2021 - 2033)
• Kidneys
• Liver
• Lung
• Heart
• Others
• Preservation Technique Outlook (Revenue, USD Million, 2021 - 2033)
• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Solution
  • 1.2.2. Organ
  • 1.2.3. Preservation Technique
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Solution outlook
  • 2.2.2. Organ outlook
  • 2.2.3. Preservation Technique outlook
  • 2.2.4. Region outlook
• 2.3. Competitive Insights

Chapter 3. Organ Presearvation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Organ Preservation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Organ Presearvation Market: Solution Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Organ Preservation Market: Solution Movement Analysis
• 4.3. Organ Preservation Market by Solution Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. University of Wisconsin (UW)
  • 4.5.1. University of Wisconsin (UW) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Custodiol HTK
  • 4.6.1. Custodiol HTK Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Perfadex
  • 4.7.1. Perfadex Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Organ Presearvation Market: Organ Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Organ Preservation Market: Organ Movement Analysis
• 5.3. Organ Preservation Market by Organ Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Kidneys
  • 5.5.1. Kidneys Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Liver
  • 5.6.1. Liver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Lung
  • 5.7.1. Lung Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Heart
  • 5.8.1. Heart Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Organ Presearvation Market: Preservation Technique Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Organ Preservation Market: Preservation Technique Movement Analysis
• 6.3. Organ Preservation Market by Preservation Technique Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Static Cold Storage
  • 6.5.1. Static Cold Storage Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Hypothermic Machine Perfusion
  • 6.6.1. Hypothermic Machine Perfusion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Normothermic Machine Perfusion
  • 6.7.1. Normothermic Machine Perfusion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Organ Presearvation Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Organ Preservation Market Movement Analysis
• 7.3. Organ Preservation Market: Regional Estimates & Trend Analysis by Solution & Organ
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Organ Preservation Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. XVIVO
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. TransMedics, Inc.
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. 21st Century Medicine
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Bridge to Life Ltd.
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Preservation Solutions, Inc.
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Global Transplant Solutions
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Organ Recovery Systems
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. CryoLife, Inc. (Artivion, Inc)
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Paragonix Technologies, Inc (Getinge)
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives